Allena Pharmaceuticals (ALNA) received notice from Nasdaq that its shares will be suspended Sep 7, 2022 04:37PM
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease Jul 19, 2022 08:00AM
Allena Pharmaceuticals Announces Completion of Enrollment of Cohorts A and B of ALLN-346 Phase 2a Study 202 in Patients with Gout and Stages 2 and 3 Chronic Kidney Disease Jul 19, 2022 08:00AM
Allena Pharmaceuticals (ALNA) Issues Clinical and Corporate Update Jan 4, 2022 05:12AM
Allena Pharmaceuticals Provides Clinical and Corporate Update Jan 4, 2022 05:00AM


Jan 4, 2022 05:00AM Allena Pharmaceuticals Provides Clinical and Corporate Update